/ Case study Institution · European Union · Lisbon · 2024 · Express project
European Drugs Agency (EUDA, ex-EMCDDA)

An institutional rebranding
delivered under pressure, no compromise.

The European agency in charge of drug monitoring changed its mandate and identity in 2024 — from EMCDDA to EUDA. Our role: align the website with the new brand from day one, without the "interim" solution showing.

/ New identity · 2024
EUDA — European Drugs Agency
EMCDDA → EUDA ● Lisbon · 2024
/ EUDA palette
#8C67FF
#00BCAD
#00B2FF
#FF37FF
/ Scope delivered
Colours
Typography
Look & feel
UI components
/ The context

A European agency changes its name.

The European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) — the European Union agency in charge of drug monitoring — underwent a major transformation in 2024: a new, broader mandate, and a new identity, the European Drugs Agency (EUDA).

For a public institution, a name change is not a cosmetic detail: it is an official act, with an effective date, and a strong expectation of consistency between the legal mandate and everything visible to the public.

/ The challenge

The deadline was non-negotiable.

The website had to reflect the new identity at the exact moment of the announcement — not after. Yet a full redesign of an institutional site of this scale takes months.

Andromede was therefore tasked with a high-stakes, time-constrained project: adapt the existing site so it carried the new brand from day one, pending a deeper redesign later.

The pitfall to avoid: an "interim" solution that shows. A European agency cannot display a visibly improvised transition.

/ The transformation

From EMCDDA
to EUDA.

A new identity, applied to the existing site down to the most discreet components — colours, typography, look and feel. Drag the handle to compare.

Before 2024
EMCDDA
European Monitoring Centre
for Drugs and Drug Addiction
Since 2024
EUDA — European Drugs Agency
🔒 euda.europa.eu
Nouveau site EUDA
🔒 emcdda.europa.eu
Ancien site EMCDDA
● Avant · EMCDDA
● Après · EUDA

/ Home page — before the rebranding (EMCDDA) and after (EUDA)

/ The method

Our approach.

This is exactly the kind of project where Andromede's positioning makes full sense for institutional organisations — pragmatism, responsiveness, and a single point of contact who owns the case end to end.

  • Fast consulting and scoping. Identify the right scope: what absolutely had to change for the new identity to be credible, and what could wait.
  • Applying the identity to the existing site. The new visual identity applied to the live site: colours reworked, fonts updated, look and feel adapted down to the most discreet components. No visitor should perceive a "half-changed" brand.
  • A step designed as a milestone. This interim rebranding is not a band-aid: it's a useful first delivery that holds the public deadline while calmly preparing the deeper redesign.
/ Tech stack

Choices made
to last.

No experimental stack. Solid, documented building blocks, with maintenance guaranteed for 10 years.

Scope
Rebranding on existing site
Disciplines
Web design · UI/UX · consulting
Identity
Colours · type · components
Method
Step-by-step delivery
Constraint
Non-negotiable official deadline
Next
Full redesign planned
/ What we delivered

The results.

  • An online presence aligned with the new EUDA identity from the official announcement.
  • A non-negotiable institutional deadline met.
  • Brand continuity preserved throughout the transition phase.
  • A full redesign now approachable at the right pace, without urgency.
/ Client side

"A rare and valuable skill for institutional organisations: knowing how to deliver fast without ever sacrificing rigour. Andromede absorbed the pressure of the schedule."

EU
European Drugs Agency
Communication & digital · EUDA · Lisbon
/ Keep reading

A deadline imposed
from outside?

Change of mandate, regulatory deadline, public announcement: we scope the bare essentials, deliver a solid milestone, prepare what comes next. Free audit within 48h.

Talk about your deadline